Clinical Trial Platforms for Seed-Stage Biotech

Clinical trial platforms for seed-stage biotech: EDC, eConsent, ePRO with 21 CFR Part 11–aligned controls. Speed, flexibility, no enterprise overhead.

21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required

Overview

Clinical Trial Platforms for Seed-Stage Biotech

Clinical trial platforms for seed-stage biotech support the earliest-stage sponsors with one platform for EDC, eConsent, and ePRO—with 21 CFR Part 11–aligned controls and emphasis on speed, flexibility, and avoiding enterprise implementation overhead. Who this is for: seed-stage biotech and very early sponsors. Typical startup constraints: tight timelines, minimal team, and need for rapid build without enterprise cycles. What to look for: one platform, rapid deployment, pricing that scales. Capture fit: one platform for EDC, eConsent, ePRO; rapid build and flexible amendments; documentation for sponsor validation (Enterprise).

Who this is for and typical startup constraints

Seed-stage biotech needs an affordable, fast stack without enterprise implementation cycles. They need one platform for consent and data capture—with full audit trail and 21 CFR Part 11–aligned controls—with speed and flexibility.

What to look for

  • One platform for EDC, eConsent, ePRO; one audit trail
  • Rapid build and deployment; no enterprise implementation overhead
  • Same 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Pricing that scales with study size
  • Documentation to support sponsor validation when required (Enterprise)

Typical startup constraints

  • Enterprise implementation cycles that delay study start
  • Heavy change control for protocol and form updates
  • Pricing and contracts built for large sponsors
  • Need for speed and flexibility without enterprise overhead

Capture fit for seed-stage biotech

  • One platform for EDC, eConsent, ePRO; speed and flexibility for seed-stage biotech
  • 21 CFR Part 11–aligned controls and HIPAA-aligned security
  • Rapid build and flexible amendments; documentation for validation (Enterprise)
  • Book demo or explore platform

Related

Clinical trial platform for early-stage biotechSoftware for small biotech clinical trialsFeatures

FAQ

Questions we hear a lot

What are clinical trial platforms for seed-stage biotech?
Clinical trial platforms for seed-stage biotech offer one platform for EDC, eConsent, ePRO—with 21 CFR Part 11–aligned controls—and emphasis on speed, flexibility, and no enterprise implementation overhead. Capture is built for early-stage and seed-stage biotech.
Is Capture 21 CFR Part 11–aligned?
Yes. Capture is designed with 21 CFR Part 11–aligned controls and HIPAA-aligned security. We provide documentation to support sponsor validation when required (Enterprise).

Ready to see Capture in action?

Explore the platform with a free sandbox. No sales call required.